文献速递临床试验与 GCP

基于虚拟现实的辅助软件对胸腔镜术后疼痛的有效性与安全性:随机对照试验研究方案

Effectiveness and safety of adjuvant software based on virtual reality for post-thoracoscopic surgery pain: study protocol for a randomized controlled trial.
PubMed 文献 · Trials · 2025-08-13

本研究为前瞻性、多中心、开放标签随机对照试验,纳入215例胸腔镜手术患者,随机分为实验组(术后标准药物镇痛联合辅助镇痛软件)与对照组(仅标准药物镇痛),以术后48小时第二次干预后NRS评分较术后24小时干预前基线的下降评估有效性,并评估安全性。

要点

  • 纳入215例胸腔镜手术患者,随机分为VR辅助镇痛软件联合标准药物镇痛组与单纯标准药物镇痛组。
  • 主要结局为术后48小时第二次干预后NRS评分较术后24小时干预前基线的下降幅度。
  • 次要结局为安全性评估。

核心结论

  • 本研究旨在探索基于虚拟现实的辅助软件作为传统镇痛治疗补充工具在胸腔镜术后疼痛管理中的潜在获益。

研究设计与样本

  • 前瞻性、多中心、开放标签随机对照试验,纳入215例胸腔镜手术患者,随机分配至两个平行组。

主要发现

  • 实验组在术后标准药物镇痛基础上接受辅助镇痛软件,对照组仅接受标准术后药物镇痛。
  • 采用数字评分量表(NRS)在干预前及术后24小时和48小时评估疼痛强度。
  • 主要结局为术后48小时第二次干预后NRS评分较术后24小时干预前基线的下降,次要结局为安全性特征。

关键数值与推荐

  • 主要结局指标为术后48小时第二次干预后NRS评分较术后24小时干预前基线的下降幅度。
  • 次要结局指标为安全性特征。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Postoperative pain can significantly impair functional recovery and diminish the quality of life in patients who have undergone thoracoscopic surgery. Virtual reality (VR), by leveraging cognitive-behavioral intervention techniques and redirecting attention from noxious stimuli, holds promise as a modality to alleviate postoperative pain. Despite this potential, current VR software for postoperative care predominantly emphasizes physical therapy and rehabilitation, often overlooking the integration of pain management strategies. The primary objective of our study is to evaluate the effectiveness and safety of an adjunctive VR-based software for pain control following thoracoscopic surgery. METHODS: This is a prospective, multicenter, open-label, randomized controlled trial involving 215 patients who have undergone thoracoscopic surgery. Participants will be randomly allocated to one of two parallel groups. The experimental group will receive postoperative adjuvant analgesic software in addition to standard postoperative pharmacological analgesia, while the control group will receive only standard postoperative pharmacological analgesia. Pain intensity will be assessed using the numerical rating scale (NRS) at pre-intervention and at 24 and 48 h post-surgery. The primary outcome measure will be the effectiveness of the VR-based adjuvant analgesic software, as assessed by the reduction in NRS scores after the second intervention at 48 h postoperatively compared to pre-intervention baseline at 24 h postoperatively, and the secondary outcome measure will assess its safety profile. DISCUSSION: Our study marks a pioneering effort to incorporate VR-based adjuvant software into the postoperative pain management regimen. We endeavor to explore an innovative approach to deliver evidence-based pain treatments. The findings of this trial aim to shed light on the potential benefits of VR as a complementary tool to traditional analgesic therapies in the context of postoperative pain management following thoracoscopic procedures. TRIAL REGISTRATION: Our protocol was retrospectively registered in the Chinese Clinical Trial Registry on August 2, 2024. The registration number was ChiCTR2400087741.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Feng X, Guo W, Jiang B, et al. Effectiveness and safety of adjuvant software based on virtual reality for post-thoracoscopic surgery pain: study protocol for a randomized controlled trial. Trials. 2025. PMID: 40804646. doi:10.1186/s13063-025-08975-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。